期刊
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
卷 26, 期 1, 页码 1-8出版社
KARGER
DOI: 10.1159/000315100
关键词
Sphingolipids; Sphingomyelinase; Enzyme Inhibitors; Drug Targets
资金
- Deutsche Forschungsgemeinschaft (DFG) [AR 376/2-1]
- Volkswagenstiftung
Despite of the importance of the acid sphingomyelinase for sphingomyelin homeostasis and sphingolipid signalling, potent and selective inhibitors for this enzyme are rare. An increasing set of data on the inhibition of acid sphingomyelinase in different disease models using indirect inhibitors has been generated and strongly implies acid sphingomyelinase as an emerging drug target. Very recently, some new and promising inhibitors from different substance classes have been developed. In this review, previous and current developments in the field are summarized. Copyright (C) 2010 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据